Single administration of atenolol does not influence the kinetics of orally given isosorbide dinitrate
Bogaert, M.G.; Rosseel, M.T.; Bruyneel, K.
International Journal of Clinical Pharmacology Research 3(6): 491-493
1983
ISSN/ISBN: 0251-1649 PMID: 6678835 Document Number: 198912
In eight subjects, plasma concentrations of isosorbide dinitrate and its mononitrates after oral administration of 10 mg isosorbide dinitrate were measured on two occasions, once with and once without previous administration of a single dose of atenolol 100 mg. There were no significant changes either in plasma concentration at different times after administration, or in peak plasma concentrations or in area under the curve of the isosorbide dinitrate and mononitrates.
Document emailed within 1 workday
Related Documents
Ellingsen, O.; Kjekshus, J. 1984: Prazosin in exercise-induced angina pectoris. An open study of work capacity after a single dose of prazosin, isosorbide dinitrate, atenolol and nifedipine Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 104(9): 657-660Vítovec, J.; Roubalík, P.; Blaha, M.; Krifta, P.; Studeník, P.; Sobotová, D.; Stejfa, M. 1988: The effect of a single administration of isosorbide dinitrate (Isoket ampules) in heart failure Vnitrni Lekarstvi 34(3): 245-251
Rotrekl, P.; Vlasínová, J.; Manousek, J.; Bocek, O.; Vlasicová, Y.; Janousek, S.; Semrád, B. 1994: The effect of diuretics on the magnitude of the effect of isosorbide dinitrate given as a single dose and after long-term administration. Ergometric study in patients with stable angina pectoris Vnitrni Lekarstvi 40(11): 693-697
Rao, Y.V.; Reddy, K.S.; Wasir, H.S. 1991: Assessment of antianginal efficacy of long-acting sustained release isosorbide dinitrate in comparison with short-acting isosorbide dinitrate Indian Heart Journal 43(2): 97-100
Koike, A.; Yajima, T.; Koyama, Y.; Shimizu, N.; Kano, H.; Kobayashi, K.; Taniguchi, K.; Marumo, F.; Hiroe, M. 1998: Effects of isosorbide dinitrate on oxygen uptake kinetics in cardiac patients Medicine and Science in Sports and Exercise 30(2): 190-194
Chasseaud, L.F.; Taylor, T.; Major, R.M.; Taylor, I.W.; Luckow, V.; Darragh, A.; Lambe, R.F. 1983: Pharmacokinetics of 14C-isosorbide dinitrate after administration in various sustained-release formulations Arzneimittel-Forschung 33(9): 1298-1301
Mahgoub, A.A.; El-Medany, A.H.; Abdulatif, A.S. 2002: A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure Saudi Medical Journal 23(6): 725-731
Richard, L.; Klein, G.; Orr, J.M. 1976: Simultaneous measurement of plasma isosorbide dinitrate, isosorbide-2-mononitrate, and isosorbide-5-mononitrate by gas-liquid chromatography Clinical Chemistry 22(12): 2060-2061
Assinder, D.F.; Chasseaud, L.F.; Hunter, J.O.; Jung, R.J.; Taylor, T. 1977: Plasma concentrations of isosorbide dinitrate after oral administration of a sustained-release formulation to human subjects Arzneimittel-Forschung 27(1): 156-158
Cervinka, J.; Kaláb, M.; Munclinger, M.; Kordac, V.; Tesar, V.; Marecek, Z.; Petrtýl, J.; Perlík, F.; Brodanová, M.; Ort, J. 1988: The effect of peroral administration of isosorbide dinitrate on portal pressure and flow in patients with liver cirrhosis Casopis Lekaru Ceskych 127(5): 140-143
Podolec, P.; Pieniazek, P.; Badacz, L.; Tracz, W. 1984: Clinical evaluation of isosorbitol dinitrate (isosorbide dinitrate) in patients with critical stenosis of coronary arteries Polski Tygodnik Lekarski 39(1): 13-15
Schneider, W.; Stahl, B.; Kaltenbach, M.; Bussmann, W.D. 1984: Differences in the production of methemoglobin during high-dose treatment with isosorbide dinitrate or isosorbide 5-mononitrate Arzneimittel-Forschung 34(12): 1779-1782
Laufen, H.; Aumann, M.; Leitold, M. 1983: Oral absorption and disposition of isosorbide dinitrate and isosorbide mononitrates in man Arzneimittel-Forschung 33(7): 980-984
Lazebnik, L.B.; Tereshchenko, S.N.; Gendel'man, A.M. 1991: Comparison of the clinical and hemodynamic effects of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate in acute myocardial infarction Kardiologiia 31(10): 13-15
Nakabayashi, S.; Uyama, O.; Nagatsuka, K.; Uehara, A.; Wanaka, A.; Yoneda, S.; Kimura, K.; Kamata, T. 1985: The effect of isosorbide dinitrate and isosorbide-5-mononitrate on prostacyclin (PGI2) and thromboxane A2 (TXA2) generation in rat and human arteries Research Communications in Chemical Pathology and Pharmacology 47(3): 323-332
Scardi, S.; Pandullo, C.; Pivotti, F.; Ceschia, G.; Pollavini, G. 1986: Hemodynamic and anti-angina effects of transdermal nitroglycerin after acute and chronic administration. Additive effect of sublingual isosorbide dinitrate Giornale Italiano di Cardiologia 16(11): 895-903
Sizova, Z.M.; Kozlova, N.V.; Zakharova, V.L.; Shameeva, E.S. 2015: Comparative Assessment of Effects of Isosorbide Dinitrate, Isosorbide-5-Mononitrate and Nicorandil on the Frequency-of Angina Attacks and Vasoregulating Endothelial Function in Patients with Ischemic Heart Disease Kardiologiia 55(2): 10-15
Kinoshita, R.; Ishida, K.; Sendaya, K.; Miyagawa, A.; Oda, S.; Taniguchi, K.; Honda, N. 1990: Clinical evaluation of isosorbide dinitrate (ISDN) spray: a study on the plasma concentrations of ISDN and on its hemodynamic effects using three administration routes Masui. Japanese Journal of Anesthesiology 39(12): 1660-1663
Baligadoo, J.S.; Chiche, P. 1979: Hemodynamic effects of nitrate derivatives: effect of initial hemodynamic parameters on the nature of the responses observed after administration of isosorbide dinitrate and trinitrin Therapie 34(5): 591-609
Döring, G. 1992: Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients Journal of Cardiovascular Pharmacology 20(Suppl 3): S74-S81